Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Enhancing Brain Lesions”

6 trials

Showing 6 of 6 results

Early research (Phase 1)Study completedNCT06224543
What this trial is testing

MR Image Synthesis With Low Gadobutrol Dose and AI

Who this might be right for
Enhancing Brain Lesions
Subtle Medical 60
Testing effectiveness (Phase 2)Ended earlyNCT02038049
What this trial is testing

Assess the Effect of a Single Infusion of VAY736 on Disease Activity in Patients With Relapsing-remitting Multiple Sclerosis

Who this might be right for
Relapse Remitting Multiple Sclerosis
Novartis Pharmaceuticals 8
Not applicableStudy completedNCT00226304
What this trial is testing

Evaluation of Brain Lesions in HIV-infected Patients for Diagnosis of Primary Central Nervous System Lymphoma

Who this might be right for
HIV InfectionsLymphoma, AIDS-Related
National Institutes of Health Clinical Center (CC) 120
Post-approval studies (Phase 4)Study completedNCT00764387
What this trial is testing

Contrast Enhanced MRI of the CNS - Patients With Known Cerebral Neoplastic Lesions.

Who this might be right for
Neoplastic CNS Lesions
Bayer 166
Not applicableStudy completedNCT01604512
What this trial is testing

A Comparison of MRI Perfusion and FDG PET/CT to Distinguish Between Radiation Injury and Tumor Progression

Who this might be right for
Brain Cancer
Memorial Sloan Kettering Cancer Center 148
Post-approval studies (Phase 4)WithdrawnNCT00037115
What this trial is testing

Induction Therapy With a Single High Dose Bolus of Intravenous Methotrexate With Leucovorin Rescue, Prior to Initiation of AVONEX® Treatment, in Patients Presenting With a First Acute Demyelinating Event.

Who this might be right for
Demyelinating DisordersMultiple SclerosisOptic Neuritis+2 more
MidAmerica Neuroscience Research Foundation at Rowe Neurology Institute

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation